Patient P-01843
Synthetic patientNBL-101 · Day 107 · 55–64 · M · baseline S14Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Improving
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
96%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S14
- Day 48 Trajectory diverged from prediction — Observed response fell below the model's expected path.
- Day 49 SC-12 recommended — Supportive Compound SC-12
- Day 50 Patient accepted — Started SC-12 in the companion
- Day 56 No meaningful change — Supportive Compound SC-12
What changed?
Trajectory began diverging from predicted response on Day 48.
Primary contributors, last 14 days
- Toxicity-12
- Inflammatory activity-6
- GI instability+4
- Nutritional resilience+2
What helped?
- Supportive Compound SC-12Day 49Result: no meaningful change
LIFE OS recommendation
GI Support Protocol GI-04
92%
probability of meaningful tolerance improvement
- 284 similar trajectories
- 83% showed improvement
- median effect visible after 8 days
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion69.4/100
improving · -3.7 vs previous 14 d
Toxicity
Blood41.3/100
improving · -2.9 vs previous 14 d
Sleep quality
Wearable38/100
improving · +7.8 vs previous 14 d
Energy level
Daily log2.7/10
improving · +0.3 vs previous 14 d
Stress level
Daily log6.9/10
stable · -0.2 vs previous 14 d
Steps
Wearable4,018
improving · +278 vs previous 14 d
Adherence
Companion46.8 %
improving · +2.5 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards restoration · 25 from the failing basin, 71 from restoration.
Would help
Would not help
- SC-12 Supportive Compoundalready tried, no meaningful change
- Keep fat lowGI +6.4 next day on high-intake days · n 22
- Keep fibre lowGI +3.3 next day on high-intake days · n 20
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Dietary fat load+6.4detractor · 95%
- Insoluble fibre+3.3detractor · 79%
- Spicy / capsaicin-1.4no signal · 27%
- Histamine load-0.7no signal · 18%
- Alcohol+0.4no signal · 15%
- Simple carbohydrates+0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓80
- MicrobiomeButyrate capacity 44/100
- MicrobiomeF. prausnitzii depleted
- Daily logFibre intake low in recent food logs
- Mucosal barrier integrity ↓50
- MicrobiomeAkkermansia low → thinner mucus layer
- Daily logGI symptom score 69 and rising
- Inflammatory signalling ↓25
- BloodInflammatory load index 58
- Drug metabolism and exposure ↑20
- BloodToxicity index 41
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 3.1 · butyrate capacity 44/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 40 ms
- Sleep
- 7.1 h
- Steps
- 4,751
- Resting HR
- 69 bpm
Daily log: GI score 69, nutritional resilience 38, adherence 47.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
- Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Track each bowel movement today: time, stool form, urgency, overnight waking
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- Electrolyte solution, one sachet after any loose stool
- Fictional demo item: oral nutrition supplement with lunch
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-01689 | 19% | S13 | BR-03 | no change | 50 |
| P-01350 | 18% | S19 | BR-03 | no change | 34 |
| P-01708 | 30% | S07 | CR-01 | improved | 59 |
| P-01371 | 25% | S06 | CR-01 | improved | 63 |
| P-01388 | 25% | S17 | CR-01 | improved | 59 |
| P-01835 | 25% | S17 | CR-01 | improved | 56 |
| P-01877 | 25% | S01 | CR-01 | improved | 67 |
| P-01696 | 24% | S20 | CR-01 | improved | 59 |
| P-01442 | 22% | S13 | CR-01 | improved | 61 |
| P-01430 | 19% | S05 | CR-01 | improved | 54 |
| P-01767 | 19% | S14 | DT-01 | no change | 63 |
| P-01342 | 18% | S11 | DT-01 | improved | 48 |